CYP2E1 and metabolic dysfunction-associated steatohepatitis: It also has been hypothesized that increased hepatic expression of CYP2E1 (variant allele CYP2E15), carries out omega hydroxylation of fatty acids, leads to increased levels of toxic lipid peroxides and its possible increased expression in NASH (39).